Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection
Clinical trial NCT01371578 · COMPLETED
Trial details
- NCT number
- NCT01371578
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.